Abstract
Rapid Improvement of Patient-Reported Outcomes with Venetoclax Plus Obinutuzumab in Patients with Previously Untreated CLL and Coexisting Conditions: A Prospective Analysis from the CLL14 Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have